Sign up to save your podcasts
Or
Share The pathway to COVID-19 vaccination
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
The pathway to COVID-19 vaccination
A COVID-19 vaccine breakthrough would have a material impact on global stock markets, so will we see a vaccine in 2021? One of the world's leading experts in vaccine development believes it's more than likely.
Dr Michael Farzan, Professor and Chair of the Department of Immunology and Microbiology at Scripps Research Institute discusses the pathway to COVID-19 vaccination with Antipodes Healthcare Sector Head, Dr Nick Cameron.
View all episodes
By Antipodes Partners
5
11 ratings
A COVID-19 vaccine breakthrough would have a material impact on global stock markets, so will we see a vaccine in 2021? One of the world's leading experts in vaccine development believes it's more than likely.
Dr Michael Farzan, Professor and Chair of the Department of Immunology and Microbiology at Scripps Research Institute discusses the pathway to COVID-19 vaccination with Antipodes Healthcare Sector Head, Dr Nick Cameron.
More shows like Good Value | Pragmatic Value Investing
View all
The Meb Faber Show - Better Investing
943 Listeners
NAB Morning Call
20 Listeners
The Money Puzzle
45 Listeners
Capital Allocators – Inside the Institutional Investment Industry
797 Listeners
The Diary Of A CEO with Steven Bartlett
8,876 Listeners
Trillions
196 Listeners
money money money
52 Listeners
The Rules of Investing
13 Listeners
Equity Mates Investing Podcast
61 Listeners
Australian Investors Podcast
21 Listeners
Value Investing with Legends
208 Listeners
The Memo by Howard Marks
435 Listeners
Chanticleer
22 Listeners
The Fin
20 Listeners
Australian Retirement Podcast
11 Listeners